<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Spontaneously arising <z:e sem="disease" ids="C0242647,C0334633" disease_type="Neoplastic Process" abbrv="">immunocytomas</z:e> in Lou/Wsl rats contain a consistent translocation between chromosomes 6 and 7 </plain></SENT>
<SENT sid="1" pm="."><plain>The c-myc gene has been localized to chromosome 7 and has been shown to be rearranged in the majority of the rat <z:e sem="disease" ids="C0242647,C0334633" disease_type="Neoplastic Process" abbrv="">immunocytomas</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We now report the cloning of the rearranged 11-kilobase EcoRI c-myc fragment from the IgE-secreting IR75 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Sequence analysis revealed that the cytogenetically visible t(6;7) translocation must have involved several events in this <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>One event has led to the juxtaposition of c-myc and the switch mu region, in a head-to-head orientation </plain></SENT>
<SENT sid="5" pm="."><plain>The breakpoint is approximately 850 base pairs upstream from the proximal c-myc promoter on chromosome 7 </plain></SENT>
<SENT sid="6" pm="."><plain>This area is distinct from the more common mouse <z:hpo ids='HP_0011857'>plasmacytoma</z:hpo>- and Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>-associated translocation breakpoints and also differs from the known murine retroviral insertion sites </plain></SENT>
<SENT sid="7" pm="."><plain>A second rearrangement has led to the transposition of sequences upstream from the switch gamma 1 region to the c-myc-distant end of the switch mu region, tail-to-tail </plain></SENT>
<SENT sid="8" pm="."><plain>This requires at least two events, including one inversion </plain></SENT>
<SENT sid="9" pm="."><plain>In addition to showing that identical loci (c-myc, immunoglobulin) are juxtaposed via chromosomal translocations in three different <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, mouse <z:hpo ids='HP_0011857'>plasmacytoma</z:hpo>, and rat <z:e sem="disease" ids="C0242647,C0334633" disease_type="Neoplastic Process" abbrv="">immunocytoma</z:e>) in different species (human, mouse, and rat), the multiple rearrangements in IR75 and some other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> emphasize the selective value of c-myc activation by an immunoglobulin locus in the tumorigenic process </plain></SENT>
</text></document>